• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. GII OXINIUM FEM SIZE 7 RIGHT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. GII OXINIUM FEM SIZE 7 RIGHT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Catalog Number 71420156
Medical Device Problem Codes Device Dislodged or Dislocated (2923); Unintended Movement (3026)
Health Effect - Clinical Code Subluxation (4525)
Date of Event 11/29/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H10: internal complaint reference (b)(4).
 
Event or Problem Description
It was reported that, after right tka was performed in 2022, the patient noted that the femur would sublux from the tibia when doing a single leg squat and then rotating.The surgeon indicated this was a very unusual movement, for which a revision surgery was performed on (b)(6) 2023 implanting a legion hinge system to provide maximum stability.Patient is currently mobilizing well.
 
Additional Manufacturer Narrative
The devices were not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, the reported patient activities (single leg squats), illicit drug use, and prior multi-ligament reconstruction (2022) all likely contributed to the event.The patient impact included the described ¿unusual movement¿ during single leg squat and rotating, likely secondary to the subluxation, in addition to the revision/conversion to a right total knee arthroplasty.A post-operative restorative phase would be anticipated.Further patient impact cannot be determined based on the information provided.Devices batch number were not provided, thus, an evaluation of the manufacturing records could not be performed.For the femoral component, base plate and insert, a review of complaint history for the part number over the past 12 months and for the batch number based on historical data of the device did not reveal similar events for the listed device.A review of the instructions for use documents for knee system revealed that dislocation has been identified in possible adverse effects section as a result from trauma, improper implant selection, improper implant positioning, improper fixation, and/or migration of the components.Muscle and fibrous tissue laxity can also contribute to these conditions.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to these products and event.At this time, we have no reason to suspect that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include traumatic injury, patient condition or abnormal loading of limb.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GII OXINIUM FEM SIZE 7 RIGHT
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key18383599
Report Number1020279-2023-02563
Device Sequence Number14893034
Product Code JWH
UDI-Device Identifier03596010430816
UDI-Public03596010430816
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K021673
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number71420156
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/29/2023
Supplement Date Received by Manufacturer01/24/2024
Initial Report FDA Received Date12/22/2023
Supplement Report FDA Received Date01/25/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GNSII CMT TIB SZ5 RT(PN:71420186); LGN CR FLX XLP SZ5-6 9MM(PN:71453121)
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexUnknown
-
-